Stock screener

PROK

Conviction 20HealthcareScan · Mon, Aug 10, 2026
PROK$1.69+3.05%
ResistanceSupportVol 14
63 bars
Vol MA14 1.12M
May 11May 28Jun 16Jul 6Jul 23Aug 10
PROKIDNEY CORP.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.prokidney.com
Price1.69
Change+3.05%
Gap+0.91%
Rel volume5.88×
Avg volume1.12M
Avg $ vol1.79M
SMA 201.58
SMA 501.71
SMA 2002.06
Price vs 50-1.31%
Price vs 200-18.02%
MA stackbearish
50/200 cross
Supertrenddown · 1.82
RSI (14)54
MACD hist0.02
MACD crossbull · 5d
Stoch %K / %D96 / 84
ADX (14)13
+DI / −DI21 / 15
RSI divergence
MACD divergence
ATR %+5.46%
ADR %4.82%
52w high3.30
52w low1.50
From 52w high-48.79%
Above 52w low+12.67%
New 52w highNo
SqueezeOn · 3d
Bollinger width13.07%
%B1.02
Donchian pos96.00%
Donchian high1.70
Donchian low1.45
AVWAP (52w high)2.08
vs AVWAP high-18.72%
AVWAP (52w low)1.61
vs AVWAP low+5.10%
OBV trendUp
Chaikin MF (20)0.15
Today vs 20d5.88×
Avg vol (14d)1.12M
Avg vol (20d)1.12M
Avg $ vol (20d)1.79M
Market cap104M
RS 3m (vs SPY)-18.46%
RS 6m (vs SPY)-19.32%
RS line new highNo
Trend template0/8
Technical rank31.7
1 week+8.33%
1 month-3.98%
3 months-9.14%
6 months-9.63%
1 year-34.11%
YTD-24.22%
P/E-1.51
P/B-0.12
P/S116.46
P/FCF-0.77
EPS-0.2300
Div yield
ROE7.81%
ROA-27.70%
Debt/Eq
Current8.36
EV/EBITDA-0.18
Gross margin
Net margin
Rev growth1075.00%
EPS growth-12.75%
Price target
Target upside
Analyst rating
Institutional
Ent. value29.13M
Revenue150K
Net income-28.42M
Gross profit
Free cash flow-135.31M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out205.2M
Employees231
ListedTue, Jul 12, 2022
Free float102.88M
Float %72.7%
Short interest20.91M
Days to cover15.8d
Short volume85.8%
Squeeze score100 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction20 / 100
Pattern quality
Tech rank31.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance2.22
Support1.48
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 26 – Jun 29
    2 scans
  2. Breaking out now
    Jun 30
    1 scan
  3. Setting up
    Jul 1
    1 scan

Congress activity

Disclosed STOCK Act trades in PROK

All disclosures →
No recent disclosed trades by Congress in PROK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PROK · 7 buys

InsiderSideShares
Legorreta Pablo G.
Director · Director stock option (right to buy) · 2026-05-28
Grant135K
Jimenez Santos Jose Ignacio
Director · Director stock option (right to buy) · 2026-05-28
Grant135K
Sinha Uma
Director · Director stock option (right to buy) · 2026-05-28
Grant135K
Lotvin Alan
Director · Director stock option (right to buy) · 2026-05-28
Grant135K
Fox Jennifer A.
Director · Director stock option (right to buy) · 2026-05-28
Grant135K
DOYLE WILLIAM F
Director · Director stock option (right to buy) · 2026-05-28
Grant135K
Pereira Brian JG
Director · Director stock option (right to buy) · 2026-05-28
Grant135K

SEC filings

EDGAR filings in PROK

EDGAR →

No recent SEC filings on file for PROK.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.